Cryolife Profit Margin

The latest profit margin for CRY is 2.55% as of March 2026. That compares with -5.49% in the prior-year period — up 146.5% year over year. That is below the Healthcare sector average of 19.13%. Investors often review this figure alongside Cryolife's historical trend and sector peers before judging valuation or financial health.

Over the past year, CRY's profit margin moved from -5.49% to 2.55% — a 146.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cryolife's valuation or profitability profile.

Against Healthcare companies, CRY currently prints 2.55% for profit margin, while the sector average sits near 19.13%. That is roughly 86.7% below the sector mean. Large gaps often invite a closer look at Cryolife's growth, margins, and balance sheet.

Profit Margin shows how effectively Cryolife converts resources into returns. At 2.55%, CRY may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -5.49% in the prior-year period — up 146.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CRY's profit margin (2.55%), review year-over-year change from -5.49%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.